Work

Long-Term Efficacy and Safety of Recombinant Human Hyaluronidase (rHuPH20)- Facilitated Subcutaneous Infusion of Immunoglobulin G (IgG) (HyQvia; IGHy) in Patients with Primary Immunodeficiencies (PI)

Year: 2015

Type: article

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2014.12.1247

Authors: Richard L. Wasserman, Mark R. Stein, Isaac Melamed, Lisa J. Kobrynski, Sudhir Gupta, Jennifer M. Puck, Arye Rubinstein, Werner Engl, Barbara McCoy, Heinz Leibl, Leman Yel

Institutions: Allergy Associates of the Palm Beaches, IMMUNOe Research Center, Emory University, University of California, Irvine, University of California, San Francisco, Albert Einstein College of Medicine, Baxter (Austria), Baxter (United States)

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2118914113

FWCI: 0.328

Cites:

Cited by: 2

Related to: 10